Efficacy and Safety of Darolutamide in Combination With Androgen-Deprivation Therapy and Docetaxel in Black Patients From the Randomized ARASENS Trial

Neal D. Shore; Maha Hussain; Fred Saad; Karim Fizazi; Cora N. Sternberg; David Crawford; Bertrand Tombal; Luke Nordquist; Michael Cookson; Frank Verholen; Jay Jhaveri; Shankar Srinivasan; Matthew R. Smith

doi:10.1093/oncolo/oyad254

Back

Efficacy and Safety of Darolutamide in Combination With Androgen-Deprivation Therapy and Docetaxel in Black Patients From the Randomized ARASENS Trial

Journal article

Peer reviewed

Efficacy and Safety of Darolutamide in Combination With Androgen-Deprivation Therapy and Docetaxel in Black Patients From the Randomized ARASENS Trial

Neal D. Shore, Maha Hussain, Fred Saad, Karim Fizazi, Cora N. Sternberg, David Crawford, Bertrand Tombal, Luke Nordquist, Michael Cookson, Frank Verholen, …

The oncologist (Dayton, Ohio), Vol.29(3), pp.235-243

03/01/2024

DOI: https://doi.org/10.1093/oncolo/oyad254

PMID: 37812679

Abstract

androgen receptor inhibitor

Black

darolutamide

metastatic hormone-sensitive prostate cancer

safety

survival analyses

Files and links (1)

url

https://doi.org/10.1093/oncolo/oyad254View

Published (Version of record) Open

Metrics

1 Record Views

Details

Title: Efficacy and Safety of Darolutamide in Combination With Androgen-Deprivation Therapy and Docetaxel in Black Patients From the Randomized ARASENS Trial
Creators: Neal D. Shore - Carolina Urologic Research Center
Maha Hussain - Northwestern University
Fred Saad - Centre Hospitalier de l’Université de Montréal
Karim Fizazi - Université Paris-Saclay
Cora N. Sternberg - New York Hospital Queens
David Crawford - University of California San Diego
Bertrand Tombal - Cliniques Universitaires Saint-Luc
Luke Nordquist - Research Network (United States)
Michael Cookson - Oklahoma State University Oklahoma City
Frank Verholen - Bayer (Switzerland)
Jay Jhaveri - Bayer (United States)
Shankar Srinivasan - Bayer (United States)
Matthew R. Smith - Massachusetts General Hospital
Publication Details: The oncologist (Dayton, Ohio), Vol.29(3), pp.235-243
Number of pages: 9
Grant note: Orion Corporation (http://data.elsevier.com/vocabulary/SciValFunders/501100024580) Bayer Fund (http://data.elsevier.com/vocabulary/SciValFunders/100015340) Bayer HealthCare (http://data.elsevier.com/vocabulary/SciValFunders/501100000801)
Identifiers: 991006262305702656
Academic Unit: Radiology
Language: English
Resource Type: Journal article